<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" public-private="public" dms-id="H987035A876D54FB7A05145C9B9EC78B6" key="H">
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 3037 IH: Access to Breast Cancer Diagnosis Act of 2025</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-04-28</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code>
<congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session>
<legis-num display="yes">H. R. 3037</legis-num>
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
<action display="yes">
<action-date date="20250428">April 28, 2025</action-date>
<action-desc><sponsor name-id="D000624">Mrs. Dingell</sponsor> (for herself, <cosponsor name-id="F000466">Mr. Fitzpatrick</cosponsor>, and <cosponsor name-id="W000797">Ms. Wasserman Schultz</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc>
</action>
<legis-type>A BILL</legis-type>
<official-title display="yes">To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations.</official-title>
</form>
<legis-body style="OLC" display-enacting-clause="yes-display-enacting-clause" id="HE399B14A23584D1292D962659741B8F2">
<section section-type="section-one" id="HCE136CDE482940B3BD2F16E3706629FA"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Access to Breast Cancer Diagnosis Act of 2025</short-title></quote>.</text></section> <section id="HDBEC46C5D5B44849AA79C01C1B6CB046"><enum>2.</enum><header>Requiring diagnostic and supplemental breast examinations to be covered with no cost-sharing requirements</header> <subsection id="H36913C0ADAF146D29EC3356FC5C5F817"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Subpart II of part A of title XXVII of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300gg-11">42 U.S.C. 300gg–11 et seq.</external-xref>) is amended by adding at the end the following new section:</text>
<quoted-block style="OLC" display-inline="no-display-inline" id="H5C0FD29CC80B4BD79F5D4179C00689ED">
<section id="HDBFBC5A11999406A95E010A4017A3A7C"><enum>2730.</enum><header>Diagnostic and supplemental breast examinations</header>
<subsection id="H070FD9A281774FB8B54BA812EAAF6FB0"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">In the case of a group health plan, or a health insurance issuer offering group or individual health insurance coverage, that provides benefits with respect to diagnostic and supplemental breast examinations furnished to an individual enrolled under such plan or such coverage, such plan or coverage shall not impose any cost-sharing requirements for these benefits.</text></subsection> <subsection id="H633830A9951C443790BD9B8FC98C3221"><enum>(b)</enum><header>Construction</header><text>Nothing in this section shall be construed—</text>
<paragraph id="H1050484955194612B13C5741256FBA66"><enum>(1)</enum><text display-inline="yes-display-inline">to prohibit a group health plan or health insurance issuer from requiring timely prior authorization or imposing other appropriate utilization controls in approving coverage for any diagnostic and supplemental breast examination; or</text></paragraph> <paragraph id="HC17C50C28FB04D69A130A05FBD36B4BC"><enum>(2)</enum><text display-inline="yes-display-inline">to supersede a State law that provides greater protections with respect to the coverage of diagnostic and supplemental breast examinations than is provided under this section.</text></paragraph></subsection>
<subsection id="H4FEC0F7CECC14406BA8FCA36C3DA38BC"><enum>(c)</enum><header>Definitions</header><text>In this section:</text> <paragraph id="H284B82E9465640E4B22105F120248771"><enum>(1)</enum><header>Cost-sharing requirements</header><text>The term <term>cost-sharing requirements</term> means a deductible, coinsurance, copayment, and any maximum limitation on the application of such a deductible, coinsurance, copayment or similar out-of-pocket expense.</text></paragraph>
<paragraph id="H4DBBA83B3776455082C686F579580E89"><enum>(2)</enum><header>Diagnostic breast examination</header><text display-inline="yes-display-inline">The term <term>diagnostic breast examination</term> means a medically necessary and appropriate (in accordance with National Comprehensive Cancer Network Guidelines) examination of the breast (including, but not limited to such an examination using diagnostic mammography, breast magnetic resonance imaging, or breast ultrasound) that is—</text> <subparagraph id="H0ED43DF85BCE4E259D4C8925B9739FBD"><enum>(A)</enum><text>used to evaluate an abnormality seen or suspected from a screening examination for breast cancer; or</text></subparagraph>
<subparagraph id="H301160EAA0994EBEA5CE805E19FB3F4D"><enum>(B)</enum><text>used to evaluate an abnormality detected by another means of examination.</text></subparagraph></paragraph> <paragraph id="H0B3298A57BDF4A85B7343878C71839C5"><enum>(3)</enum><header>Supplemental breast examinations</header><text display-inline="yes-display-inline">The term <term>supplemental breast examination</term> means a medically necessary and appropriate (in accordance with National Comprehensive Cancer Network Guidelines) examination of the breast (including, but not limited to such an examination using breast magnetic resonance imaging or breast ultrasound) that is—</text>
<subparagraph id="HCD3C6585AADF43FEA0A9DC4E55E34242"><enum>(A)</enum><text>used to screen for breast cancer when there is no abnormality seen or suspected; and</text></subparagraph> <subparagraph id="HD86F5EED762041B2BBC21ABEB0A75E79"><enum>(B)</enum><text>furnished based on personal or family medical history or additional factors that may increase the individual’s risk of breast cancer.</text></subparagraph></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></subsection>
<subsection id="H0FA24274B8A04D4D86121697BCA27AB5"><enum>(b)</enum><header>Application to grandfathered health plans</header><text>Section 1251(a)(4)(A) of the Patient Protection and Affordable Care Act (<external-xref legal-doc="usc" parsable-cite="usc/42/18011">42 U.S.C. 18011(a)(4)(A)</external-xref>) is amended—</text> <paragraph id="H660617D0462147B3ADEF2269F6732F23"><enum>(1)</enum><text>by striking <quote>title</quote> and inserting <quote>title, or as added after the date of the enactment of this Act</quote>; and</text></paragraph>
<paragraph id="HE43F1CE55D0C44658754C2F51324C9C9"><enum>(2)</enum><text>by adding at the end the following new clause:</text> <quoted-block style="OLC" display-inline="no-display-inline" id="H65093017A57849FBA33E7835B93B039C"> <clause id="H8C1D43EDA6AB47B0910EC830C5224A1F"><enum>(v)</enum><text display-inline="yes-display-inline">Section 2730 (relating to coverage for diagnostic and supplemental breast examinations).</text></clause><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection>
<subsection commented="no" id="HD2589B493AA045E9AA24599CA6A7F3DD"><enum>(c)</enum><header>Application to high deductible health plans with health savings account eligibility</header><text><external-xref legal-doc="usc" parsable-cite="usc/26/223">Section 223(c)(2)</external-xref> of the Internal Revenue Code of 1986 is amended by adding at the end the following:</text> <quoted-block style="OLC" display-inline="no-display-inline" id="H61056FBEAB05400496609ECB331002A4"> <subparagraph commented="no" id="H164F3D4BB8464A6F8F3ACA659E1249C4"><enum>(H)</enum><header>Safe harbor for absence of deductible for diagnostic and supplemental breast examinations</header><text display-inline="yes-display-inline">In the case of plan years beginning on or after January 1, 2026, a plan shall not fail to be treated as a high deductible health plan by reason of failing to have a deductible for diagnostic and supplemental breast examinations.</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection>
<subsection id="H23862EDB16534A9895A9AAE98A42388F"><enum>(d)</enum><header>Effective date</header><text>The amendments made by this section shall apply with respect to plan years beginning on or after January 1, 2026.</text></subsection></section> </legis-body> </bill>

